Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Cardiology/Vascular Diseases | Hematology
Thrombosis Clinical Trials
A listing of Thrombosis medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.
Alabama
Birmingham : University of Alabama at Birmingham
Clarification of Optimal Anticoagulation Through Genetics
Dothan :
A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis
Montgomery :
A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis
Arizona
Glendale : Arrowhead Hospital/Phoenix Heart, PLLC
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Phoenix : Phoenix Children's Hospital
Evaluation of the Duration of Therapy for Thrombosis in Children
Arkansas
Little Rock : Arkansas Children'S Hospital
Pediatric Catheter-related Thrombosis Imaging Study
California
Los Angeles :
Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects
Los Angeles :
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
Orange : St. Joseph Hospital
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
San Diego : Rady Children's Hospital UCSD
Evaluation of the Duration of Therapy for Thrombosis in Children
San Francisco : University of California San Francisco
Clarification of Optimal Anticoagulation Through Genetics
View More »
Santa Clara : Abbott Vascular
EXCEL Clinical Trial
Stanford : Stanford University Medical Center
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Colorado
Aurora : University Of Colorado Denver
Pediatric Catheter-related Thrombosis Imaging Study
Denver : University of Colorado School of Medicine
Evaluation of the Duration of Therapy for Thrombosis in Children
Connecticut
Danbury : Danbury Hospital
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Norwich : Eastern Connecticut Hematology and Oncology Associates
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Delaware
Newark : Christiana Care Health Systems
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
District of Columbia
Florida
Clearwater :
A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis
Ft. Myers :
A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis
Gainesville : University of Florida
Clarification of Optimal Anticoagulation Through Genetics
Orlando : Florida Hospital
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Sarasota :
A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis
View More »
St. Petersburg : All Children's Hospital
Evaluation of the Duration of Therapy for Thrombosis in Children
Tampa : Pepin Heart Hospital / University Community Hospital
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Georgia
Atlanta :
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
Augusta : Georgia Health Sciences University
Clarification of Optimal Anticoagulation Through Genetics
Jonesboro :
A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis
Illinois
Chicago : University of Illinois at Chicago
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Chicago :
Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects
Hinsdale : Adventist Midwest Health
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Springfield : Southern Illinois University
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Winfield : Central DuPage Hospital
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Indiana
Indianapolis : CorVasc
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Lafayette :
A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis
Iowa
Iowa City : University of Iowa Carver's College of Medicine
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Kentucky
Florence : St. Elizabeth Healthcare of Northern Kentucky
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Paducah :
A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis
Louisiana
Covington :
A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis
New Orleans : Tulane University Health Science Center
Clarification of Optimal Anticoagulation Through Genetics
Maine
Portland : Maine Medical Center
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Maryland
Baltimore : Johns Hopkins Bayview Medical Center
A Pilot Study Comparing Enoxaparin to Fondaparinux to Prevent Venous Thromboembolism (VTE) in Bariatric Surgical Patients
Baltimore :
A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis
Baltimore : University of Maryland School of Medicine
Clarification of Optimal Anticoagulation Through Genetics
Randallstown :
A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis
Massachusetts
Boston : Massachusetts General Hospital
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Michigan
Ann Arbor : Ann Arbor Veteran's Administration Health System
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Ann Arbor : University of Michigan Medical Center
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Detroit : Henry Ford Health System
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Detroit : Henry Ford Hospital
Clarification of Optimal Anticoagulation Through Genetics
Detroit : Children's Hospital of Michigan, Wayne State University
Evaluation of the Duration of Therapy for Thrombosis in Children
View More »
East Lansing : Michigan State University
Evaluation of the Duration of Therapy for Thrombosis in Children
Minnesota
Rochester : Mayo Clinic
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Rochester : Mayo Clinic College of Medicine
Clarification of Optimal Anticoagulation Through Genetics
Missouri
Kansas City : Children'S Mercy Hospital And Clinics
Pediatric Catheter-related Thrombosis Imaging Study
Saint Louis :
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
St. Louis : Washington University School of Medicine
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
St. Louis : Washington University School of Medicine
Clarification of Optimal Anticoagulation Through Genetics
Montana
Butte :
A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis
Nebraska
Lincoln : Saint Elizabeth Regional Medical Center
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
New Jersey
Teaneck : Holy Name Hospital
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
New Mexico
Albuquerque : University of New Mexico
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
New York
Bronx : Montefiore Medical Center
Clarification of Optimal Anticoagulation Through Genetics
Buffalo : Kaleida Health System
A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion
New York : Cornell Weill Medical Center
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
New York : Mount Sinai School of Medicine
Clarification of Optimal Anticoagulation Through Genetics
New York : Weill Medical College of Cornell University
Diagnostic Utility of Contrast Echocardiography for Detection of LV Thrombi Post ST Elevation Myocardial Infarction
View More »
New York :
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
Rochester :
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
Staten Island : Staten Island University Hospital
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Valhalla :
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
North Carolina
Raleigh : Rex Healthcare
AMPLIFY- A Safety and Efficacy Trial Evaluating the Use of Apixaban in the Treatment of Symptomatic Deep Vein Thrombosis and Pulmonary Embolism
View More »
Chapel Hill : University of North Carolina at Chapel Hill
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Durham :
A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis
Durham : Duke University
Clarification of Optimal Anticoagulation Through Genetics
Durham : Duke University
Evaluation of the Duration of Therapy for Thrombosis in Children
Durham :
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
Winston Salem : Wake Forest University Baptist Medical Center
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Winston Salem :
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
Winston-Salem : Forsyth Medical Center
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
North Dakota
Bismarck : Legacy Pharma Research
Prevention of venous thromboembolism (VTE) in cancer patients at high risk for VTE and who are undergoing chemotherapy
Ohio
Cincinatti : Good Samaritan Hospital
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Cincinnati : Cincinnati Children'S Hospital Medical Center
Pediatric Catheter-related Thrombosis Imaging Study
Cleveland : Cleveland Clinic
A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion
Cleveland : Cleveland Clinic
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Colombus : Univeristy Medical Center
STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism
View More »
Columbus : Riverside Methodist Hospital
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Columbus : Nationwide Children's Hospital
Evaluation of the Duration of Therapy for Thrombosis in Children
Columbus :
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
Toledo : Jobst Vascular Center
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Oklahoma
Oklahoma City : University of Oklahoma Health Sciences Center, Department of Medicine, PO Box 26901
Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)
Oregon
Portland : Oregon Health & Science University
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Pennsylvania
Bethlehem : St. Luke's Hospital and Health Network
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Camp Hill :
A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis
Ephrata :
A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis
Philadelphia : Temple University Hospital
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Philadelphia : Albert Einstein Medical Center
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
View More »
Philadelphia : Hospital of the University of Pennsylvania
Clarification of Optimal Anticoagulation Through Genetics
Philadelphia : The Children'S Hospital Of Philadelphia
Pediatric Catheter-related Thrombosis Imaging Study
Pittsburgh : University of Pittsburgh Medical Center Presbyterian Shadyside
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Pittsburgh : Allegheny General Hospital
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Pittsburgh : The Western Pennsylvania Hospital
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Pittsburgh : Children'S Hopsital Of Pittsburgh Of Upmc
Pediatric Catheter-related Thrombosis Imaging Study
Pittsburgh :
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
Sellersville :
A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis
West Reading : The Reading Hospital and Medical Center
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Rhode Island
Providence : Rhode Island Hospital
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
South Carolina
Charleston : Medical University of South Carolina
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Charleston : Medical Center of South Carolina
STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism
Tennessee
Nashville : Vanderbilt University
Clarification of Optimal Anticoagulation Through Genetics
Nashville : Vanderbilt University
Evaluation of the Duration of Therapy for Thrombosis in Children
Texas
Dallas : University of Texas Southwestern
Evaluation of the Duration of Therapy for Thrombosis in Children
Fort Worth : Cook Children's Hospital
Evaluation of the Duration of Therapy for Thrombosis in Children
Galveston : University of Texas Medical Branch
Clarification of Optimal Anticoagulation Through Genetics
Houston : Texas Children's Cancer Center, Baylor College of Medicine
Evaluation of the Duration of Therapy for Thrombosis in Children
Houston : Texas Children'S Hospital
Pediatric Catheter-related Thrombosis Imaging Study
View More »
Houston : Ut Health/Gulf States Hemophilia & Thrombophilia Ctr.
Pediatric Catheter-related Thrombosis Imaging Study
Utah
Murray : Intermountain Medical Center
Clarification of Optimal Anticoagulation Through Genetics
Salt Lake City : University of Utah
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Salt Lake City : University of Utah Health Care
Clarification of Optimal Anticoagulation Through Genetics
Salt Lake City :
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
Virginia
Charlottesville : University of Virginia Health System
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Fredericksburg :
A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis
Washington
Tacoma :
A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis
Wisconsin
Marshfield : Marshfield Clinical Research Foundation
Clarification of Optimal Anticoagulation Through Genetics
Milwaukee : Medical College of Wisconsin/Froedtert Hospital
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Wauwatosa : Medical College of Wisconsin, Blood Center of Wisconsin
Evaluation of the Duration of Therapy for Thrombosis in Children
Argentina
Buenos Aires : Local Institution
Pediatric Catheter-related Thrombosis Imaging Study
Australia
Liverpool :
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
Melbourne :
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
Melbourne : Royal Melbourne hospital
The Effect of Enoxaparin Sodium on the Incidence of Deep Vein Thrombosis Following Electrophysiology Studies and Radiofrequency Ablation.
Parkville :
Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects
Wooloongabba :
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
Austria
Graz :
Oral Rivaroxaban in Children With Venous Thrombosis
Graz :
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
Many Locations :
Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy
Vienna : Local Institution
Pediatric Catheter-related Thrombosis Imaging Study
Vienna :
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
View More »
Wien :
Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects
Belgium
Antwerp :
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
Brussels : Erasme Hospital, Brussels
A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion
Brussels :
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
Edegem : University Hospital Antwerp
A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion
Genk : Ziekenhuis Oost Limburg, Campus St. Jan
A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion
View More »
Ghent : Drug Research Unit Ghent
A Healthy Volunteer Study to Investigate the Blood Concentrations, the Effect on Blood Clotting and the Safety of Multiple Doses of DPOC-4088 Tablets in Different Doses.
Leuven : Chirurgie UZ Leuven
A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion
Leuven :
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
Namur :
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
Bulgaria
Sofia : Clinic of Vascular Surgery and Angiology
A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion
Sofia : Tokuda Hospital Sofia
A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion
Sophia :
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
Canada
Edmonton :
A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis
Edmonton : Local Institution
Pediatric Catheter-related Thrombosis Imaging Study
Edmonton :
Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects
Hamilton :
Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects
Hamilton : St. Joseph's Healthcare Hamilton
The Risk of Venous Clotting in Patients After Renal Transplant
View More »
Hamilton : St Joseph's Healthcare Hamilton
Use of Low Molecular Weight Heparin (Tinzaparin) to Treat Blood Clots in Patients With Kidney Failure
Montréal : Maisonneuve Rosemont Hospital
STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism
Ottawa : Local Institution
Pediatric Catheter-related Thrombosis Imaging Study
Toronto : St. Michael's Hospital
Atorvastatin for the Treatment of Retinal Vein Occlusion
Toronto : Local Institution
Pediatric Catheter-related Thrombosis Imaging Study
Czech Republic
Ostrava - Vitkovice : Vascular Centre Vitkovicka Nemocnice
A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion
Prague : IKEM, Kardiologicka klinika
A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion
Prague : University Hospital Kralovske Vinobrady
A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion
Prague : Cevni Chirurgie, Nemocnice Na Homolce
A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion
Prague 2 : Institute of Hematology and Blood Transfusion, Coagulation Laboratory, U nemocnice 1
Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)
View More »
Usti nad Labem : Chirurgicka klinika IPVZ
A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion
Denmark
Many Locations :
Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy
France
Caen :
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
Dijon : University Hospital
STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism
Grenoble : University Hospital
STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism
Many Locations :
Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy
Montelimar : Cabinet
Elastic Compression Stockings for Prevention of Post-thrombotic Syndrome
View More »
Paris : Unite de Recherches Therapeutiques, Hopital Lariboisiere
Vitamin K2 Intervention in Patients With Vitamin K Antagonists
Germany
Aachen :
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
Baesweiler : Chriurgische Praxisklinik
Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux
Berlin :
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
Berlin : DEutsches Rotes Kreuz Schwesternschaft Berlin Gemeinnütziges Krankenhaus GmbH
Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux
Bonn : Universitätsklinikum Bonn, Radiologische Universitätsklinik
A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion
View More »
Bonn : Universitäts-Hautklinik Bonn
Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux
Dortmund :
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
Dresden : Universitäts GefäßCentrum Uniklinikum Dresden
A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion
Dresden : Universitätsklinikum Dresden
Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux
Freiburg : Local Institution
Pediatric Catheter-related Thrombosis Imaging Study
Freiburg : Hautarztpraxis
Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux
Hannover : Local Institution
Pediatric Catheter-related Thrombosis Imaging Study
Hannover :
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
Karlsbach : Akademie für Gefäßkrankheiten e.V.
Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux
Köln :
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
Leipzig : Klinik für Innere Medizin I - Angiologie / Kardiologie
A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion
Mainz :
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
Mannheim :
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
Many Locations :
Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy
Mühldorf am Inn : Kardiologie Mühldorf am Inn
Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux
Munchen :
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
München : Gemeinschaftspraxis Mietaschk, Bilderling, Kaiser, Tato
Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux
India
Gujarat : Life Care Institute of Medical Sciences and Research
A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion
Karnataka : Gokula Metropolis Clinical Research Centre, M. S. Ramaiah Hospital
A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion
Israel
Haifa :
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
Jerusalem :
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
Petach Tikva :
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
Tel Hashomer :
Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects
Italy
Bologna : University Hospital
STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism
Catania :
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
Foggia :
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
Genova :
Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects
Milan : IRCCS H San Raffaele
STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism
View More »
Milan :
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
Reggio Emilia :
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
Rome :
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
Torino :
Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects
Japan
Chuo-ku : St. Luke's International Hospital
AStudy To Evaluate Safety And Eficacy Of Apixaban In Japanese Acute Deep Vein Thrombosis (DVT) And Pulmonary Embolism (PE) Patients
Kashihara city : Nara Medical University, Department of Blood Transfusion Medicine, Shijyo-cho 840
Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)
Tsu : Mie University Hospital
AStudy To Evaluate Safety And Eficacy Of Apixaban In Japanese Acute Deep Vein Thrombosis (DVT) And Pulmonary Embolism (PE) Patients
Mexico
Col. Secc Xvi Tlalpan : Local Institution
Pediatric Catheter-related Thrombosis Imaging Study
Monterrey : Local Institution
Pediatric Catheter-related Thrombosis Imaging Study
Netherlands
Amsterdam : Local Institution
Pediatric Catheter-related Thrombosis Imaging Study
Norway
Trondheim : Trondheim University St Olavs Hospital, Department of Hematology, PO Box 3250 Sluppen
Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)
Peru
Lima : Instituto Neuro Cardiovascular de las Americas
A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion
Lima : Centro de Investigación y Atención Cardiovascular
A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion
Lima : Hospital Nacional Edgardo Rebagliati Martins
A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion
Lima : Hospital Nacional Guillermo Almenara Irigoyen-EsSalud
A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion
Poland
Bytom : Wojewodzki Szpital Specjalistyczny nr 4 w Bytomiu
A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion
Chrzanow : Malopolskie Centrum Sercowo-Naczyniowe PAKS American Heart of Poland Sp. z o.o
A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion
Gdansk : Uniwersyleckie Centrum Kliniczne
A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion
Poznan : Szpital Kliniczny Przemienienia Panskiego Uniwersytetu Medycznego im. Karola Marcinkowskiego w Poznaniu
A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion
Poznan : Zaklad Opieki Zdrowonej Ministerstwa Spraw Wewnetrznych i Administracji w Poznaniu
A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion
View More »
Szczecin : Samodzielny Publiczny Szpital Kliniczny Nr 2 PUM w Szczecinie
A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion
Romania
Bucharest :
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
Bucuresti : Institutul de Urgenta pentru Boli Cardiovasculare "Prof.Dr.C.C.Iliescu"
A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion
Cluj-Napoca : Institutul Inimii "Nicolae Stancioiu" Cluj-Napoca
A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion
Iasi : Inst.de Boli Cardiovasculare "Prof.I.M.Georgescu" Iasi
A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion
Targu Mures : Institutul de Boli Cardiovasculare si Transplant Mures
A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion
Serbia
Beograd : Klinicki Centar Srbije
A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion
Beograd : Institut za kardiovaskularne bolesti Dedinje
A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion
Nis : Klinicki Centar Nis
A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion
Novi Sad : Klinicki Centar Vojvodine
A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion
Slovakia
Spain
Alcorcon : Fundacion Hospital Alcorcon
A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion
Alicante : University Hospital
STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism
Badalona :
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
Many Locations :
Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy
Sevilla :
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
View More »
Soria : General Hospital
STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism
Valencia :
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
Sweden
Many Locations :
Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy
Stockholm : Karolinska University Hospital
Compression Treatment Effects on Complications and Healing of Achilles Tendon Rupture
Switzerland
Bern : University Clinic of Hematology and Central Hematology Laboratory, Bern University Hospital and the University of Bern, Inselspital
Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)
Bern :
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
Many Locations :
Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy
Tunisia
Tunis : Hospital Charle Nicolle
Echo-Doppler Assessment of the Occurrence of Asymptomatic DVT in Orthopedic Replacement Surgery Under Enoxaparin
United Kingdom
Glasgow : Local Institution
Pediatric Catheter-related Thrombosis Imaging Study
Liverpool :
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
London : Local Institution
Pediatric Catheter-related Thrombosis Imaging Study
London :
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)